Active ingredient consisting of a mixture of polylysine compounds and use in the prevention of strokes and the treatment of the post-stroke inflammatory phase

Abstract

The invention relates to an active ingredient consisting of several polylysine compounds, said polylysine compounds consisting of at least one small molecule conjugated to a polylysine, said active ingredient comprising at least the following polylysine compounds: Coenzyme Q10-Polylysine Retinoic Acid-Polylysine Cysteine-Polylysine Taurine-Polylysine Glutathione-Polylysine, for use in humans or animals, to prevent strokes and/or treat the inflammatory phase following a stroke.

Dependencies are inferred from the claim text.